Assessment of Postoperative Pain Through Facial Expressions Using Facial Recognition Software
NCT ID: NCT04914052
Last Updated: 2022-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2021-07-25
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Commonly used methods for pain assessment include the use of self-reports from patients, or observers assessments.
However, both techniques are subjective to bias. Therefore, automatic assessment of pain based on objective data would enable individualized patient care, optimize provided anesthesia treatment and analgesic regimes.
While research has shown that facial expressions are valid indicators of pain levels, to date research has yet to yield a reliable clinical tool which can be easily implemented in clinical practice.
In this pilot study we intend to assess the feasibility, of facial expression analysis by using machine learning models of artificial intelligence (AI) to accurately predict pain levels of patients experienced in the immediate post operative period.
This pilot trial will take place in two stages:
First stage will include development of an AI algorithm that correlates facial recognition with pain levels.
Second stage will include validation of the algorithm by comparison of to standard pain assessment modalities.
In the first stage each assessment of facial expressions will be filmed in a 30 second segment and will be followed by an immediate pain assessment using two modalities, first will be pain score assessed by an anesthesiologist attending the patient at that moment, second will be VAS assessment by the participant patient. Three objective parameters: heart rate, blood pressure and respiratory rate will be recorded simultaneously from the automated record keeping system used in every patient in the recovery room (post anesthesia care unit-PACU).
These assessments will take place at different time intervals according to the investigator's decision, throughout the participant's staying in the post anesthesia care unit.
After completion of the first stage, the second stage of the study will be done in the same manner as described above regarding patients enrollment. Pain assessment will be done by VAS and physician assessment as described above but this time will be correlated with pain assessment by the algorithm developed in the first stage of the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of Postoperative Pain
NCT01449318
Pain and Disability Outcomes in Post Amputation Patients
NCT05716321
Biobehavioral Recovery From Surgery and Anesthesia
NCT00176696
Comparison of Methods for Recording Post Operative Pain
NCT06206148
Antinociceptive Modalities on Ischemia Reperfusion Injury
NCT01932918
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study participation will take place in the PACU. Upon admission to the PACU unit, all study participants' facial expressions will be videoed by a camera placed in front of the patient's bed.
The facial expressions will be filmed in 30 second segments. A pain assessment will be measured immediately following filming of each segment using two modalities:
* Pain score assessed by an attending anesthesiologist assigned to the study team.
* VAS assessment by the patient.
* Three objective parameters: heart rate, blood pressure and respiratory rate will be recorded simultaneously from the automated record keeping system used in every patient in the PACU The quantity of segments filmed for each of the participants will be decided by the investigator taking into account participant's cooperation level and VAS levels.
In order to engineer an accurate predictive model the dataset will also include participants reporting a VAS of 0- experiencing no pain.
Data Management:
Following data collection, the data will be forwarded in a coded manner, according to Clalit's data security regulations, to Third Eye systems a facial recognition software company.
For first stage Third Eye systems will analyze and process the data using AI and machine learning models and develop an algorithm that can predict pain level by watching facial expressions.
After completion of the first stage, the second stage of the study will be done in the same manner as described above regarding patients enrollment. Pain assessment will be done by VAS and physician assessment as described above but this time will be correlated with pain assessment by the algorithm developed in the first stage of the study.
This feasibility study is pilot study to examine whether there is a positive correlation, on a relatively small sample size analysis, using simple resources and limited data to perform this study.
In the event that a positive hypothesis can be confirmed, a second stage observational study with a large sample size and an increased data source will be investigated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Patients will be requested to sign an informed consent in which they will agree to have their face filmed in the post-anesthesia care unit.
The facial expressions will be filmed in 30 second segments. A pain assessment will be measured immediately following filming of each segment using two modalities:
* Pain score assessed by an attending anesthesiologist assigned to the study team.
* VAS assessment by the patient. Following data collection, the data will be forwarded in a coded manner, according to Clalit's data security regulations, to Third Eye systems a facial recognition software company.
Third Eye systems will analyze and process the data using AI and machine learning models and develop an algorithm that can predict pain level by watching facial expressions.
Filming facial expressions
Study participants' facial expressions will be videoed by a camera placed in front of the patient's bed during their stay in the post anesthesia care unit.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Filming facial expressions
Study participants' facial expressions will be videoed by a camera placed in front of the patient's bed during their stay in the post anesthesia care unit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients unable to sign an informed consent
* Patients with a history of psychiatric disease.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Third eye systems
UNKNOWN
Rabin Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rabin Medical Center/Beilinson Campus
Petah Tikva, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0778-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.